The present invention relates to novel compounds which are pyrazolo[1,5-a]pyrimidines, and which modulate the activity of peroxisome proliferator-activated receptors (PPAR) &agr; and/or &ggr;. The said compounds are predicted to be useful in the treatment of metabolic diseases, e.g. type II diabetes.
本发明涉及新型化合物,它们是
吡唑并[1,5-a]
嘧啶,并且调节
过氧化物酶体增殖物激活受体(
PPAR)α和/或γ的活性。这些化合物被预测可用于治疗代谢性疾病,例如2型糖尿病。